Search

everythinglearnresearchcommunity

for

Search:↓

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Alopecia patients have less GPER-1, which might affect hair loss.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Androgen levels do not determine the type of PCOS symptoms in young females.

Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Lowering certain hormone levels improves treatment for hair loss in young men.

Women with PCOS have lower zinc levels.

Lower adiponectin levels are linked to higher insulin resistance in women with PCOS.

Low vitamin D levels may affect ovulation and progesterone in infertile women.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Changing light exposure boosts hormone levels and antioxidant activity, improving cashmere growth in goats.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Serum triglyceride levels are not linked to prostate cancer risk.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.